Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FVM-04 neutralizes EBOV and SUDV in animal models

April 25, 2016

BL-84, a genetically optimized banana lectin for influenza

April 25, 2016

Achaogen awarded contract option by NIAID to support LpxC inhibitor research

April 22, 2016

NITD-008 and galidesivir improve survival and reduce viremia in AG129 mouse model of ZIKV infection

April 22, 2016

Lead Discovery Siena discloses guanidine derivatives

April 22, 2016

US Phytotherapy demonstrates dengue virus inhibition in preliminary cell culture studies

April 22, 2016

Genticel reports additional 12-month data from phase II trial of GTL-001

April 21, 2016

Eiger licenses PEGylated interferon lambda-1a rights from Bristol-Myers Squibb

April 21, 2016

N & N Pharmaceuticals begins phase I trial of N-MCT

April 21, 2016

Bristol-Myers Squibb patents NS5B inhibitors

April 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...